Skip to main content

Advertisement

SpringerLink
Log in

Prognostic value of normal stress myocardial perfusion imaging and ventricular function in Japanese patients with chronic kidney disease: a study based on the J-ACCESS-3 database

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Background

The purpose of this study is to test the hypothesis that a normal myocardial perfusion imaging (MPI) study in chronic kidney disease (CKD) can provide benign prognostic information for the prediction of major cardiovascular events.

Methods

The study group consisted of 431 CKD patients (males, 64%; mean age, 72 ± 11 years) with normal SPECT imaging. Based on SPECT image and QGS data, 331 had a summed stress score of 3 or less, a summed difference score of 1 or less and normal cardiac function (males; end-systolic volume (ESV) ≤ 60 ml, females; ESV ≤ 40 ml, males, ejection fraction (EF) ≥ 49%; females, EF ≥ 50%).

Results

During a 3-year follow-up period, there were a total of 27 major cardiovascular events, including cardiac death (n = 3), sudden death (n = 3), and acute coronary syndrome (n = 3), and 19 were hospitalized because of congestive heart failure. Kaplan–Meier analysis showed that the number of major cardiovascular events in patients with higher eGFR of ≥ 15 ml/min) were very few, and regarded as low risk. According to the eGFR status, namely < 15 (n = 58), 15 to < 30 (n = 97), 30 to < 45 (n = 131), ≥ 45 (n = 45), the higher cardiac event rate was observed in patients with eGFR of < 15 ml/min among the four groups. The major cardiovascular event rate in patients with the lowest eGFR (< 15) was twice as much than that in patients with eGFR of ≥ 30 ml/min. Lower hemoglobin (males, < 12 g/dl; females, < 11 g/dl) and higher CRP (CPR ≥ 0.3 mg/dl) were also the predictors of increased risk.

Conclusions

Normal stress SPECT images confer a benign prognosis in patients with CKD, but care must be taken for severely reduced renal function, which was associated with higher cardiac event.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risk of death, cardio vascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.

    Article  PubMed  CAS  Google Scholar 

  2. Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S. Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study. Eur J Nucl Med Mol Imaging. 2009;35:319–28.

    Article  Google Scholar 

  3. Yamasaki Y, Nakajima K, Kusuoka H, Izumi T, Kashiwagi A, Kawamori R, et al. Prognostic value of gated myocardial perfusion imaging for asymptomatic patients with type 2 diabetes: the J-ACCESS 2 investigation. Diabetes Care. 2010;33:2320–6.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Nakamura S, Kawano Y, Nakajima K, Hase H, Joki N, Hatta T, et al. Prognostic study of cardiac events in Japanese patients with chronic kidney disease using ECG-gated myocardial perfusion imaging: final 3-year report of the J-ACCESS 3 study. J Nucl Cardiol. 2017; https://doi.org/10.1007/s12350-017-0880-5.

  5. Joki N, Hase H, Kawano Y, Nakamura S, Nakajima K, Hatta T, et al. Myocardial perfusion imaging for predicting cardiac events in Japanese patients with advanced chronic kidney disease: 1-year interim report of the J-ACCESS 3 investigation. Eur J Nucl Med Mol Imaging. 2014;41:1701–9.

    Article  PubMed  Google Scholar 

  6. Nakajima K, Matsuo S, Okuda K, Wakabayashi H, Tsukamoto K, Nishimura T. Estimation of cardiac event risk by gated myocardial perfusion imaging and quantitative scoring methods based on a multi-center J-ACCESS database. Circ J. 2011;75:2417–23.

    Article  PubMed  Google Scholar 

  7. Matsuo S, Nakajima K, Horie M, Nakae I, Nishimura T. Prognostic value of normal stress myocardial perfusion imaging in Japanese population. Circ J. 2008;72:611–7.

    Article  PubMed  Google Scholar 

  8. Matsuo S, Nakajima K, Yamasaki Y, Kashiwagi A, Nishimura T. Prognostic value of normal stress myocardial perfusion imaging and ventricular function in Japanese asymptomatic patients with type 2 diabetes—a study based on the J-ACCESS-2 database. Circ J. 2010;74:1916–21.

    Article  PubMed  CAS  Google Scholar 

  9. Herzog CA, Asinger RW, Berger AK, Chartan DM, Diez J, Hart RG, et al. Cardiovascular disease in chronic kidney disease. A clinical update from kidney disease: improving global outcomes (KIDIGO). Kidney Int. 2011;80:572–86.

    Article  PubMed  Google Scholar 

  10. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol. 1995;26:639–47.

    Article  PubMed  CAS  Google Scholar 

  11. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511.

    Article  PubMed  Google Scholar 

  12. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single-photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998;97:535–43.

    Article  PubMed  CAS  Google Scholar 

  13. Hasebroock KM, Serkova NJ. Toxicity of MRI and CT contrast agents. Expert Opin Drug Metab Toxicol. 2009;5:403–16.

    Article  PubMed  CAS  Google Scholar 

  14. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117:1283–91.

    Article  PubMed  Google Scholar 

  15. Matsuo S, Matsumoto T, Nakae I, Koh T, Masuda D, Takada M, et al. Prognostic value of ECG-gated thallium-201 single-photon emission tomography in patients with coronary artery disease. Ann Nucl Med. 2004;18:617–22.

    Article  PubMed  Google Scholar 

  16. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–16.

    Article  PubMed  CAS  Google Scholar 

  17. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, Nallamothu BK, Kent DM. Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet. 2009;373:911–8.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Matsuo S, Nakajima K, Onoguchi M, Wakabayash H, Okuda K, Kinuya S. Nuclear myocardial perfusion imaging using thallium-201 with a novel multifocal collimator SPECT/CT: IQ-SPECT versus conventional protocols in normal subjects. Ann Nucl Med. 2015;29:452–9.

    Article  PubMed  Google Scholar 

  19. Matsuo S, Nakajima K, Okuda K, Kinuya S. The relationship between stress-induced myocardial ischemia and coronary artery atherosclerosis measured by hybrid SPECT/CT camera. Ann Nucl Med. 2011;25:650–6.

    Article  PubMed  Google Scholar 

  20. Berman D, Hachamovitch R, Lewin H, Friedman J, Shaw L, Germano G. Risk stratification in coronary artery disease: implications for stabilization and prevention. Am J Cardiol. 1997;79:10–6.

    Article  PubMed  CAS  Google Scholar 

  21. Gibbons RJ, Hodge DO, Berman DS, Akinbonoye OO, Heo J, Hachamovitch R, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation. 1999;23:2140–5.

    Article  Google Scholar 

  22. Hakeem A, Bhatti S, Dillie KS, Cook JR, Samad Z, Roth-Cline MD, et al. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death. Circulation. 2008;118:2540–9.

    Article  PubMed  Google Scholar 

  23. Hatta T, Nishimura S, Nishimura T. Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease. Eur J Nucl Med Mol Imaging. 2009;36:1835–41.

    Article  PubMed  Google Scholar 

  24. Wada H, Hohi T, Miyauchi K, Doi S, Naito R, Konishi H, et al. Independent and combined effects of serum albumin C-reactive protein on long-term outcomes of patients undergoing percutaneous coronary intervention. Circ J. 2017;81:1293–300.

    Article  PubMed  Google Scholar 

  25. Underwood SR, Godman B, Salyani S, Ogle JR, Ell PJ. Economics of myocardial perfusion imaging in Europe: the EMPIRE study. Eur Heart J. 1999;20:157–66.

    Article  PubMed  CAS  Google Scholar 

  26. Yoshinaga K. Current clinical practice of nuclear cardiology in Japan. Ann Nucl Cardiol. 2016;2:50–2.

    Article  Google Scholar 

  27. Matsuo S. Phase analysis using gated myocardial perfusion single-photon emission computed tomography imaging for evaluating cardiac dyssynchrony. Circ J. 2012;76:1832–3.

    Article  PubMed  Google Scholar 

  28. Soneson H, Hedeer F, Arévalo C, Carlsson M, Engblom H, Ubachs JF, et al. Development and validation of a new automatic algorithm for quantification of left ventricular volumes and function in gated myocardial perfusion SPECT using cardiac magnetic resonance as reference standard. J Nucl Cardiol. 2011;18:874–85.

    Article  PubMed  Google Scholar 

  29. Gimelli A, Liga R, Magro S, Novo S, Pedrinelli R, Petronio AS, et al. Evaluation of left ventricular mass on cadmium-zinc-telluride imaging: validation against cardiac magnetic resonance. J Nucl Cardiol 2017.

Download references

Acknowledgements

The J-ACCESS-3 study was supported by a grant from the Japan Cardiovascular Research Foundation. We thank the many physicians and technologists in the 62 hospitals who participated in the J-ACCESS-3 study for their cooperation.

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takaramachi, Kanazawa, 920-8641, Japan

    Shinro Matsuo & Kenichi Nakajima

  2. Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan

    Yasuchika Takeishi

  3. Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajiicho Kawaramachi Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan

    Tsunehiko Nishimura

Authors
  1. Shinro Matsuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenichi Nakajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuchika Takeishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tsunehiko Nishimura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Shinro Matsuo or Tsunehiko Nishimura.

Ethics declarations

Conflict of interest

All authors have no COI.

Disclosure

None.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matsuo, S., Nakajima, K., Takeishi, Y. et al. Prognostic value of normal stress myocardial perfusion imaging and ventricular function in Japanese patients with chronic kidney disease: a study based on the J-ACCESS-3 database. Eur J Nucl Med Mol Imaging 45, 1101–1107 (2018). https://doi.org/10.1007/s00259-018-3956-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-018-3956-9

Keywords

Search

Navigation